These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26977521)

  • 1. [Good efficacy and safety profile in clinical practice].
    MMW Fortschr Med; 2015 Nov; 157(20):66-7. PubMed ID: 26977521
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of rivaroxaban in real-life patients with atrial fibrillation.
    Barón-Esquivias G; Fernández-Avilés F; Atienza F; Pastor Pueyo P; Toro R; Sanmartín Fernández M
    Expert Rev Cardiovasc Ther; 2015 Apr; 13(4):341-53. PubMed ID: 25797900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation of rivaroxaban in patients with nonvalvular atrial fibrillation at the primary care level: the Swiss Therapy in Atrial Fibrillation for the Regulation of Coagulation (STAR) Study.
    Engelberger RP; Noll G; Schmidt D; Alatri A; Frei B; Kaiser WE; Kucher N
    Eur J Intern Med; 2015 Sep; 26(7):508-14. PubMed ID: 25935131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Real life clinical management of nonvalvular atrial fibrillation: results from the Italian epidemiological survey eXperience on the use of rivaroxaban].
    Colonna P; Ammirati F;
    G Ital Cardiol (Rome); 2016 Nov; 17(11):932-939. PubMed ID: 27996999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of inpatient rivaroxaban versus warfarin on hospital-based outcomes when used for stroke prevention in patients with anticoagulant naïve, new-onset nonvalvular atrial fibrillation.
    Hurley C; Dai S; Sobieraj DM
    Int J Cardiol; 2015 Aug; 192():1-2. PubMed ID: 25981569
    [No Abstract]   [Full Text] [Related]  

  • 6. Rivaroxaban-induced hemorrhagic pericardial tamponade in end-stage renal disease.
    Rapista N; Sarkar S; Chaudhary R
    J Thromb Thrombolysis; 2020 Nov; 50(4):982-983. PubMed ID: 32495012
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous thrombolysis for acute ischemic stroke in a patient receiving rivaroxaban.
    Landais A; Ginoux C
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):e73-4. PubMed ID: 25561312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study confirms rivaroxaban favorable safety profile].
    Vetter C
    MMW Fortschr Med; 2016 Mar; 158(6):79. PubMed ID: 27084173
    [No Abstract]   [Full Text] [Related]  

  • 9. Spontaneous, Life-Threatening Hemorrhagic Cardiac Tamponade Secondary to Rivaroxaban.
    Kham NM; Song M
    Am J Ther; 2016; 23(4):e1128-31. PubMed ID: 26035030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of rivaroxaban in a cohort of 142 patients with nonvalvular atrial fibrillation treated with rivaroxaban for the prevention of stroke.
    Cerezo-Manchado JJ; Navarro-Almenzar B; Elvira-Ruiz G; García-Candel F; Flores-Blanco PJ; Caro-Martínez C; Manzano-Fernández S; García-Iniesta N; Sánchez-García J; Cabañas-Perianes V; Moraleda-Jiménez JM
    Future Cardiol; 2018 May; 14(3s):31-37. PubMed ID: 29848091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivaroxaban in the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation: Clinical Implications of the ROCKET AF Trial and Its Subanalyses.
    Spencer RJ; Amerena JV
    Am J Cardiovasc Drugs; 2015 Dec; 15(6):395-401. PubMed ID: 26062914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban.
    Camm AJ; Coleman CI; Larsen TB; Nielsen PB; Tamayo CS
    Thromb Haemost; 2018 May; 118(S 01):S45-S60. PubMed ID: 29566414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of prothrombin time to rivaroxaban in Japanese patients with non-valvular atrial fibrillation: Characteristics of 5 representative reagents in Japan (CVI ARO 1).
    Suzuki S; Yamashita T; Kasai H; Otsuka T; Sagara K
    Thromb Res; 2017 Feb; 150():73-75. PubMed ID: 28043042
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation.
    Tamayo SG; Simeone JC; Nordstrom BL; Patel MR; Yuan Z; Sicignano NM; Peacock WF
    J Am Coll Cardiol; 2016 Sep; 68(10):1144-6. PubMed ID: 27585515
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient-Reported Treatment Satisfaction with Rivaroxaban for Stroke Prevention in Atrial Fibrillation. A French Observational Study, the SAFARI Study.
    Hanon O; Chaussade E; Gueranger P; Gruson E; Bonan S; Gay A
    PLoS One; 2016; 11(12):e0166218. PubMed ID: 27935987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.
    Martínez-Rubio A; Dan GA; Kaski JC
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):933-47. PubMed ID: 24948333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.
    Krause M; Henningsen A; Torge A; Juhl D; Junker R; Kenet G; Kowalski D; Limperger V; Mesters R; Anonymous ; Rocke A; Shneyder M; Clausnizer H; Schiesewitz H; Nowak-Göttl U
    Thromb Res; 2016 Dec; 148():145-151. PubMed ID: 27687905
    [No Abstract]   [Full Text] [Related]  

  • 18. Rivaroxaban: from ROCKET-AF trial to routine practice in Spain.
    Escobar Cervantes C
    Future Cardiol; 2018 May; 14(3s):1-2. PubMed ID: 29848088
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of rivaroxaban in extreme elderly patients with atrial fibrillation: Analysis of the Shikoku Rivaroxaban Registry Trial (SRRT).
    Bando S; Nishikado A; Hiura N; Ikeda S; Kakutani A; Yamamoto K; Kaname N; Fukatani M; Takagi Y; Yukiiri K; Fukuda Y; Nakaya Y
    J Cardiol; 2018 Feb; 71(2):197-201. PubMed ID: 28969968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy.
    Sholzberg M; Xu Y
    JAMA; 2018 Oct; 320(14):1485-1486. PubMed ID: 30242329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.